These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38016395)

  • 1. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review.
    Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ
    Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Privileged s-triazines: structure and pharmacological applications.
    Shah DR; Modh RP; Chikhalia KH
    Future Med Chem; 2014 Mar; 6(4):463-77. PubMed ID: 24635525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
    Verma T; Sinha M; Bansal N
    Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications.
    Kushwaha N; Sharma CS
    Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazine as a promising scaffold for its versatile biological behavior.
    Singla P; Luxami V; Paul K
    Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.
    Khatir ZZ; Irannejad H
    Mini Rev Med Chem; 2021; 21(19):2874-2928. PubMed ID: 33719962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities.
    Singh S; Mandal MK; Masih A; Saha A; Ghosh SK; Bhat HR; Singh UP
    Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000363. PubMed ID: 33760298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expeditious synthesis and biological evaluation of novel 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials.
    Gravestock D; Rousseau AL; Lourens AC; Moleele SS; van Zyl RL; Steenkamp PA
    Eur J Med Chem; 2011 Jun; 46(6):2022-30. PubMed ID: 21420762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Activity of s-Triazine Derivatives: A Systematic Review.
    Dai Q; Sun Q; Ouyang X; Liu J; Jin L; Liu A; He B; Fan T; Jiang Y
    Molecules; 2023 May; 28(11):. PubMed ID: 37298753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry discoveries among 1,3,5-triazines: recent advances (2000-2013) as antimicrobial, anti-TB, anti-HIV and antimalarials.
    Patel RV; Keum YS; Park SW
    Mini Rev Med Chem; 2014; 14(9):768-89. PubMed ID: 24958216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse Synthetic Approaches and Biological Activities of Lucrative Pyrimidine- Triazine Hybrid Derivatives: A Review.
    Asgaonkar K; Patil S; Pradhan K; Tanksali S; Jain J
    Curr Org Synth; 2023; 20(7):734-757. PubMed ID: 36125826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
    Liu H; Long S; Rakesh KP; Zha GF
    Eur J Med Chem; 2020 Jan; 185():111804. PubMed ID: 31675510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents.
    Katiyar SB; Srivastava K; Puri SK; Chauhan PM
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4957-60. PubMed ID: 16168643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
    Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
    Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review.
    Kumar R; Singh AD; Singh J; Singh H; Roy RK; Chaudhary A
    Mini Rev Med Chem; 2014 Jan; 14(1):72-83. PubMed ID: 24387709
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Dubey P; Pathak DP; Ali F; Chauhan G; Kalaiselvan V
    Curr Drug Discov Technol; 2024; 21(2):e170723218813. PubMed ID: 37461340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
    Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
    Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
    Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
    Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal significance of benzothiazole scaffold: an insight view.
    Sharma PC; Sinhmar A; Sharma A; Rajak H; Pathak DP
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):240-66. PubMed ID: 23030043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.